Hetero Diels-Alder Reactions of Enantiopure α,β-Unsaturated Sulfinimines
FULL PAPER
20
endo I. Ϫ Tetrahydropyridine 20a: [α]D ϭ ϩ178.0 (c ϭ 0.5,
127.90, 127.98, 129.06, 130.43, 130.57, 137.54, 137.80, 138.89,
1
CHCl3). Ϫ H NMR (300 MHz, CDCl3): δ ϭ 0.99 (s, 9 H, tBuO), 138.98, 139.31, 140.15, 143.09, 149.13 (aryl-C and C-2). Ϫ MS (70
2.13 (ddd, J ϭ 13.6, 6.8, 2.6 Hz, 1 H, 5-Ha), 2.25 (ddd, J ϭ 13.6, eV, FD); m/z (%): 389.1 (12) [Mϩ Ϫ CN], 352.2 (13) [Mϩ Ϫ MeS
4.9, 4.9 Hz, 1 H, 5-Hb), 2.39 (s, 3 H, Tol-CH3), 3.64 (ddd, J ϭ 6.8, Ϫ Me], 350.2 (100) [Mϩ Ϫ MeS Ϫ Me Ϫ H2], 273.1 (67) [Mϩ
Ϫ
4.9, 1.0 Hz, 1 H, 4-H), 5.26 (dd, J ϭ 4.9, 2.6 Hz, 1 H, 6-H), 6.87 TolSO Ϫ H2], 139.1 (30) [TolSOϩ], 77.1 (6) [Phϩ]. Ϫ C21H22N2OS3
(d, J ϭ 1.0 Hz, 1 H, 2-H), 7.1Ϫ7.3 (m, 5 H, Ph-H), 7.21 (d, J ϭ (414.40): calcd. C 60.86, H 5.35; found C 61.04, H 5.63.
7.9 Hz, 2 H, m-Tol-H), 7.43 (d, J ϭ 7.9 Hz, 2 H, o-Tol-H). Ϫ 13C
Tetrahydropyridine 22: Reaction of sulfinimine 11 (29 mg, 0.1
NMR (75 MHz, CDCl3): δ ϭ 21.39 (Tol-CH3), 27.90 (tBu-CH3),
mmol) with the enol ether 16 (20 mg, 0.5 mmol) gave cycloadduct
37.89 (C-4), 38.18 (C-5), 75.80 [tBu-C(CH3)3], 79.48 (C-6), 92.74
22 (26 mg, 98%) as a yellow oil consisting of a mixture of four
(C-3), 119.12 (CN), 125.42, 126.74, 127.90, 128.20, 130.26, 138.85,
139.25, 140.58, 142.75 (aromatic and C-2).
diastereomers IϪIV in a ratio of 1.1:1.0:0.4:0.3. The ratio was de-
termined from the MeO and C-5 signals in the 13C-NMR spectrum.
˜
Ϫ IR (film): ν ϭ 3030 cmϪ1, 2976 (CϪH), 2208 (CN), 1618 (enam-
20
endo II. Ϫ Tetrahydropyridine 20b: [α]D ϭ Ϫ12.4 (c ϭ 0.5,
1
ine), 1072 (SϪO). Ϫ UV (CH3CN): λmax (lg ε) ϭ 257.5 (4.08). Ϫ
1H NMR (500 MHz, CDCl3): δ ϭ 1.69 (s, 3 H, 6-Me, II), 1.81 (s,
3 H, 6-Me, I), 1.82 (s, 3 H, 6-Me, III), 1.91 (s, 3 H, 6-Me, IV),
2.00Ϫ2.50 (m, 1 H, 5-Ha, IϪIV), 2.43 (s, 3 H, Tol-CH3, III and
IV), 2.47 (s, 3 H, Tol-CH3, II), 2.49 (s, 3 H, Tol-CH3, I), 2.80Ϫ3.40
(m, 1 H, 5-Hb, IϪIV), 3.31 (s, 3 H, MeO, I), 3.36 (s, 3 H, MeO,
II), 3.40 (s, 3 H, MeO, III), 3.47 (s, 3 H, MeO, IV), 3.60 (ddd, J ϭ
9.6, 5.8, 1.8 Hz, 1 H, 4-H, II), 3.70 (ddd, J ϭ 10.5, 5.7, 1.7 Hz, 1
H, 4-H, I), 3.84 (ddd, J ϭ 12.1, 6.3, 2.1 Hz, 1 H, 4-H, III), 4.09 (s,
J ϭ 16.2, 10.0, 2.3 Hz, 1 H, 4-H, IV), 6.73 (d, J ϭ 2.3 Hz, 1 H, 2-
H, IV), 6.82 (d, J ϭ 2.1 Hz, 1 H, 2-H, III), 6.87 (d, J ϭ 1.8 Hz, 1
H, 2-H, II), 6.89 (d, J ϭ 1.7 Hz, 1 H, 2-H, I), 7.10Ϫ7.62 (m, 9 H,
aryl-H, IϪIV). Ϫ 13C NMR (75 MHz, CDCl3): δ ϭ 21.47 (Tol-
CH3, II), 21.51 (Tol-CH3, I and III), 21.98 (Tol-CH3, IV), 22.77 (6-
CH3, IV), 23.92 (6-CH3, III), 25.44 (6-CH3, I), 26.72 (6-CH3, II),
26.88 (C-4, III), 37.58 (C-4, IV), 39.12 (C-4, II), 40.10 (C-4, II),
40.48 (C-5, II), 40.77 (C-5, I), 43.37 (C-5, III), 45.05 (C-5, IV),
49.85 (MeO, IV), 50.13 (MeO, II), 50.62 (MeO, III), 50.93 (MeO,
I), 88.04 (C-3, IV), 88.23 (C-3, III), 89.65 (C-3, II), 90.04 (C-3, I),
91.13 (C-6, II), 92.77 (C-6, I), 95.34 (C-6, IV), 95.64 (C-6, III),
116.83, 118.56, 118.83, 125.09, 125.17, 125.39, 125.47, 125.86,
125.90, 127.11, 127.16, 127.49, 127.53, 127.60, 127.74, 128.86,
128.95, 130.16, 130.36, 130.55, 130.59, 137.02, 137.98, 138.36,
139.05, 139.42, 139.62, 139.81, 139.86, 140.00, 140.27, 142.89,
142.99, 143.02, 143.18 (CN, aryl-C and C-2). Ϫ MS (70 eV, FD);
m/z (%): 366.5 (4) [Mϩ], 278.4 (39), 227.4 (13) [Mϩ Ϫ TolSO],
194.3, 139.2 (100) [TolSOϩ]. Ϫ C21H22N2O2S (366.47): calcd.
366.1402; found 366.1402 (MS).
CHCl3). Ϫ H NMR (300 MHz, CDCl3): δ ϭ 0.99 (s, 9 H, tBuO),
2.20 (dd, J ϭ 6.4, 3.4 Hz, 1 H, 5-Ha), 2.21 (dd, J ϭ 4.9, 4.1 Hz, 1
H, 5-Hb), 2.42 (s, 3 H, Tol-CH3), 3.69 (dd, J ϭ 6.4, 4.9 Hz, 1 H,
4-H), 5.35 (dd, J ϭ 4.1, 3.4 Hz, 1 H, 6-H), 6.84 (s, 1 H, 2-H),
7.1Ϫ7.25 (m, 5 H, Ph-H), 7.36 (d, J ϭ 7.9 Hz, 2 H, m-Tol-H), 7.56
(d, J ϭ 7.9 Hz, 2 H, o-Tol-H). Ϫ 13C NMR (75 MHz, CDCl3):
δ ϭ 21.47 (Tol-CH3), 28.25 (tBu-CH3), 37.57 (C-4), 38.53 (C-5),
75.69 [tBu-C(CH3)3], 79.06 (C-6), 91.69 (C-3), 119.16 (CN), 125.94,
126.80, 127.70, 128.70, 130.31, 138.81, 139.35, 140.65, 142.87 (aryl-
C and C-2).
exo I and exo II. Ϫ Tetrahydropyridine 20c and 20d: 1H NMR
(300 MHz, CDCl3): δ ϭ 1.31 (s, 9 H, tBuO, exo I), 1.35 (s, 9 H,
tBuO, exo II), 1.67Ϫ1.76 (m, 1 H, 5-Ha, exo I), 1.81 (ddd, J ϭ
13.2, 6.4, 3.4 Hz, 1 H, 5-Ha, exo II), 2.09Ϫ2.16 (m, 1 H, 5-Hb, exo
I and exo II), 2.39 (s, 3 H, Tol-CH3, exo II), 2.46 (s, 3 H, Tol-CH3,
exo I), 3.72 (ddd, J ϭ 12, 6.4, 4.9 Hz, 1 H, 4-H, exo II), 3.80Ϫ3.85
(m, 1 H, 4-H, exo I), 5.36 (dd, J ϭ 2.6, 1.9 Hz, 1 H, 6-H, exo I),
5.41 (dd, J ϭ 2.6, 2.2 Hz, 1 H, 6-H, exo II), 6.70 (d, J ϭ 1.9 Hz,
1 H, 2-H, exo II), 6.92 (d, J ϭ 1.9 Hz, 1 H, 2-H, exo I), 7.10Ϫ7.35
(m, 5 H, Ph-H, exo I and exo II), 7.34 (d, J ϭ 8.3 Hz, 2 H, m-Tol-
H, exo I), 7.38 (d, J ϭ 8.3 Hz, 2 H, m-Tol-H, exo II), 7.50 (d, J ϭ
8.3 Hz, 2 H, o-Tol-H, exo I), 7.50 (d, J ϭ 8.3 Hz, 2 H, o-Tol-H,
exo II). Ϫ 13C NMR (75 MHz, CDCl3): δ ϭ 21.35 (Tol-CH3, I),
26.95 (Tol-CH3, II), 29.88 (tBu-CH3, I), 31.18 (tBu-CH3, II), 39.56
(C-4, I and II), 49.44 (C-5, I and II), 76.47 [tBu-C(CH3)3, I and
II], 82.60 (C-6, I and II), 100.80 (C-3, I), 109.60 (C-3, II), 115.30
(CN, II), 115.33 (CN, I), 124.81, 125.26, 125.91, 127.57, 127.57,
128.44, 129.15, 129.33, 129.44, 129.57, 134.28, 134.74, 136.47,
141.11, 142.04, 143.59 (aryl-C and C-2).
Cycloadducts 27: Reaction of 26 (21 mg, 0.06 mmol) in CH2Cl2
at 11 kbar for a period of 4 d gave 27 (20 mg, 95%) as a yellow
Tetrahydropyridine 21: Reaction of sulfinimine 11 (88 mg, 0.3 solid consisting of a mixture of diastereomers endo I/endo II/exo I/
mmol) with the thioketene acetal 15 (54 mg, 0.5 mmol) gave the exo II in the ratio 8.5:2.3:4.9:1.0. The ratio was determined from
1
cycloadduct 21 (93 mg, 76%) as a white solid consisting of a mix-
the methyl signals in the H-NMR spectrum of the crude product.
ture of the two diastereomers I and II in a ratio of 1.8:1. The ratio
By means of column chromatography, the exo and the endo dia-
was determined from the SCH3 and 2-H signals in the 1H-NMR stereomers could be separated in amounts suitable for recording
˜
˜
spectrum. Ϫ IR (film): ν ϭ 3442 cmϪ1, 2920 (CϪH), 2208 (CN), 1H-NMR spectra. Ϫ IR (film): ν ϭ 3626 cmϪ1, 2978 (CϪH), 2206
1612 (enamine), 1254, 1238, 1102 (SϪO), 702. Ϫ UV (CH3CN): (CN), 1608 (enamine), 1490, 1454, 1286 (aryl ether), 1100, 1072
1
λmax (lg ε) ϭ 258.0 (4.20), 254.4 (4.20), 264.5 (4.18). Ϫ H NMR
(SϪO). Ϫ UV (CH3CN): λmax (lg ε) ϭ 195.0 (4.79), 262.0 (4.26).
Ϫ
(200 MHz, CDCl3): δ ϭ 2.10Ϫ2.30 (m, 1 H, 5-Ha, I and II), 2.25
13C NMR (75 MHz, CDCl3): δ ϭ 21.33 (Tol-CH3, endo I and
(s, 3 H, MeSa, I), 2.28 (s, 3 H, MeSa, II), 2.35 (s, 3 H, MeSb, II), exo I), 21.40 (Tol-CH3, endo II and exo II), 24.72 (4-CH3a, exo I),
2.39 (s, 3 H, MeSb, I), 2.46 (s, 3 H, Tol-CH3, II), 2.49 (s, 3 H, Tol- 24.91 (4-CH3b, exo I and exo II), 25.88 (4-CH3a, endo II), 26.40 (4-
CH3, I), 2.40Ϫ2.50 (m, 1 H, 5-Hb, II), 2.58 (dd, J ϭ 14.0 Hz, 5.6
CH3a, exo II), 26.88 (4-CH3a, endo I), 28.09 (4-CH3b, endo II),
Hz, 5-Hb, I), 3.80Ϫ4.00 (m, 1 H, 4-H, I and II), 6.74 (d, J ϭ 2.2 29.08 (4-CH3b, endo I), 31.63 (C-10b, endo I), 31.69 (C-10b, exo I),
Hz, 1 H, 2-H, II), 6.87 (d, J ϭ 1.8 Hz, 1 H, 2-H), 7.16 (d, J ϭ 8.3 31.75 (C-10b, endo II), 31.86 (C-10b, exo II), 39.30 (C-4a, endo I),
Hz, 2 H, Tol-m-H, I), 7.23 (d, J ϭ 8.3 Hz, 2 H, Tol-m-H, II), 40.80 (C-4a, exo II), 45.89 (C-4a, exo I), 49.36 (C-4a, endo I), 58.27
7.20Ϫ7.48 (m, 5-H, Ph-H, I and II), 7.63 (d, J ϭ 8.3 Hz, 2 H, Tol-
(C-4, endo II), 58.36 (C-4, endo I), 60.43 (C-4, exo I), 62.50 (C-5,
o-H, II), 7.64 (d, J ϭ 8.3 Hz, 2 H, Tol-o-H, I). Ϫ 13C NMR (75 endo I), 62.61 (C-5, endo II), 62.24 (C-5, exo I), 72.69 (C-5, exo II),
MHz, CDCl3): δ ϭ 13.30 (MeSa, II), 13.52 (MeSa, II), 14.8 (MeSb, 89.75 (C-1, exo I), 91.36 (C-1, endo I), 92.66 (C-1, endo II), 116.41
I and II), 21.52 (Tol-CH3, I and II), 38.62 (C-4, II), 39.25 (C-4, I), (C-7, endo II), 116.52 (C-7, endo I), 116.97 (C-7, exo II), 117.10 (C-
40.95 (C-5, II), 43.95 (C-5, I), 77.97 (C-6, I and II), 92.60 (C-3, II),
7, exo I), 118.96, 119.00, 120.48, 120.66 (CN), 120.75, 121.0, 121.09
93.85 (C-3, I), 118.15 (CN, II), 118.19 (CN, I), 125.72, 127.80, (C-9), 125.29, 125.43, 125.79, 127.11, 128.21, 128.41, 129.00,
Eur. J. Org. Chem. 1998, 1629Ϫ1637
1635